Kanae Kubo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Kanae Kubo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Kazuhiko Yamamoto
Department of Allergy and Rheumatology, The University of Tokyo Hospital, Tokyo, Japan
5 shared publications- Hiroko Kanda
The University of Tokyo
3 shared publications Shoko Tateishi
Department of Allergy and Rheumatology, Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan
2 shared publicationsToshihide Mimura
Division of Rheumatology and Applied Immunology, Department of Medicine, Saitama Medical School, Morohongo 38, Moro-cho, Iruma-gun, Saitama 350-0495, Japan
2 shared publicationsAki Yonezumi
1 shared publicationAkihiro Tojo
Division of Nephrology and Endocrinology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan
1 shared publication
Latest Publications
- 16 February 2017
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (12) , 2214-2216
Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide‐resistant ANCA‐associated glomerulonephritis
- 16 February 2017
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 20 (12) , 2214-2216
Efficacy of combination therapy with tacrolimus and mizoribine for cyclophosphamide‐resistant ANCA‐associated glomerulonephritis
- 1 October 2016
- Published by Elsevier in Kidney International
- Vol. 90 (4) , 908
Urinary phagocytic macrophages in hemophagocytic lymphohistiocytosis
- 1 October 2016
- Published by Elsevier in Kidney International
- Vol. 90 (4) , 908
Urinary phagocytic macrophages in hemophagocytic lymphohistiocytosis
- 10 August 2015
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 19 (8) , 747-762
IgG4‐related disease
Immunoglobulin G4‐related disease (IgG4‐RD) is a regional or systemic fibro‐inflammatory disease of unknown etiology. It presents a distinctive histopathological appearance of dense lymphoplasmacytic infiltrates with abundant IgG4‐positive plasma cells, storiform fibrosis and obliterative phlebitis with the appearance of inflammatory swelling or tumefactive lesions. This new disease entity includes a wide variety of diseases such as Mikulicz disease, autoimmune pancreatitis, Riedel thyroiditis, interstitial nephritis and retroperitoneal fibrosis. Glucocorticoid therapy can resolve the clinical and pathological abnormalities and impaired organ function. IgG4‐RD was recognized internationally in 2011, and new evidence has accumulated regarding its pathogenesis, clinical features and treatment. In this review, we outline our present understanding of IgG4‐RD.
- 10 August 2015
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 19 (8) , 747-762
IgG4‐related disease
Immunoglobulin G4‐related disease (IgG4‐RD) is a regional or systemic fibro‐inflammatory disease of unknown etiology. It presents a distinctive histopathological appearance of dense lymphoplasmacytic infiltrates with abundant IgG4‐positive plasma cells, storiform fibrosis and obliterative phlebitis with the appearance of inflammatory swelling or tumefactive lesions. This new disease entity includes a wide variety of diseases such as Mikulicz disease, autoimmune pancreatitis, Riedel thyroiditis, interstitial nephritis and retroperitoneal fibrosis. Glucocorticoid therapy can resolve the clinical and pathological abnormalities and impaired organ function. IgG4‐RD was recognized internationally in 2011, and new evidence has accumulated regarding its pathogenesis, clinical features and treatment. In this review, we outline our present understanding of IgG4‐RD.
- 1 June 2004
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 318 (4) , 935-940
Aire downregulates multiple molecules that have contradicting immune-enhancing and immune-suppressive functions
- 1 June 2004
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 318 (4) , 935-940
Aire downregulates multiple molecules that have contradicting immune-enhancing and immune-suppressive functions
- 1 September 2002
- Vol. 29 (9) , 2024-6
Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis.
- 1 September 2002
- Vol. 29 (9) , 2024-6
Antiinflammatory effect of simvastatin in patients with rheumatoid arthritis.